NEW YORK (GenomeWeb) – PositiveID announced today that it has formed a new subsidiary called ExcitePCR for the purposes of fully developing its Firefly Dx real-time PCR breadboard prototype pathogen detection system.

ExcitePCR, which is wholly owned by PositiveID, will own Firefly Dx. This arrangement allows for greater strategic flexibility, enabling the company to better pursue development partnerships or financing opportunities, PositiveID said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.